TOV NOVO NORDISK UKRAINE TRADE DATA ANALYSIS
Access comprehensive trade data for Tov Novo Nordisk Ukraine with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Tov Novo Nordisk Ukraine – Overview
Eximpedia analyzes Tov Novo Nordisk Ukraine export and import records, including data from 0 buyers and 4 suppliers. We provide an intelligence report of Tov Novo Nordisk Ukraine that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
Tov Novo Nordisk Ukraine Buyers, Suppliers & Shipments
Tov Novo Nordisk Ukraine import markets
Explore the Tov Novo Nordisk Ukraine import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3004310000 | 19.92 | 80 | 74.77 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004900000 | 5.10 | 9 | 8.41 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004390000 | 3.75 | 10 | 9.35 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 9018321000 | 0.05 | 8 | 7.48 |
| INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, DENTAL OR VETERINARY SCIENCES, INCLUDING SCIENTIGRAPHIC APPARATUS, OTHER ELECTROMEDICAL APPARATUS AND SIGHT-TESTING INSTRUMENTS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| DENMARK | 13.89 | 34 | 31.78 |
| BRAZIL | 7.29 | 37 | 34.58 |
| UNITED STATES | 4.88 | 5 | 4.67 |
| FRANCE | 2.66 | 21 | 19.63 |
| JAPAN | 0.05 | 8 | 7.48 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UA100200 | 28.83 | 107 | 100.00 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| SWIXX BIOPHARMA LLP SWIXX BIOPHARMA | 28.01 | 198 |
| NOVO NORDISK LLC | 28.03 | 281 |
| TOV NOVO NORDISK UKRAINE | 39.84 | 107 |
| SANOFI AVENTIS DE COLOMBIA SA | 47.03 | 292 |
| SANOFI HEALTH PRODUCTS LIMITED COMPANY | 101.76 | 4052 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| NOVO NORDISK A S | 28.03 | 2093 |
| SWIXX BIOPHARMA AG | 28.71 | 343 |
| NOVO NORDISK A S | 28.81 | 2093 |
| SANOFI AVENTIS DE PANAMA S A | 75.96 | 1464 |
| SANOFI WINTROP INDUSTRIES | 101.76 | 347 |
If you are looking to establish relationship with Tov Novo Nordisk Ukraine Automation you can save time by getting access to the key decision makers and get a detailed report.
Tov Novo Nordisk Ukraine Import Shipments
Discover the Tov Novo Nordisk Ukraine with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 3004310000 | 1. MEDICINES FOR HUMANS CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: TRESIBA« FLEXTACH«, SOLUTION FOR INJECTION, 100 U/ML, 3 ML IN A CARTRIDGE CONTAINED IN A MULTI-DOSE DISPOSABLE PEN, 5 SYRINGES PEN IN A CARDBOARD BOX SERIES NP5F337 - 6138 UNITS (ACTIVE SUBSTANCES: 1 ML OF SOLUTION CONTAINS 100 UNITS OF INSULIN DEGLUDEC* (EQUIVALENT TO 3.66 MG OF INSULIN DEGLUDEC). 1 PRE-FILLED SYRINGE PEN CONTAINS 3 ML OF SOLUTION, WHICH IS EQUIVALENT TO 300 UNITS OF INSULIN DEGLUDEC) TRADE MARK: TRESIBA, FLEXSTACH COUNTRY OF MANUFACTURE: DK MANUFACTURER: A/T NOVO NORDISK (PRODUCTION, FILLING IN PRIMARY PACKAGING AND CONTROL OF THE BEAM; ASSEMBLY, LABELING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT; QUALITY CONTROL OF THE BEAM OF THE FINISHED PRODUCT AND THE FINAL FINISHED PRODUCT; RESPONSIBLE FOR THE RELEASE) |  |
|
DENMARK | UKRAINE | 0 |
| 3004390000 | 1. MEDICINES FOR HUMANS CONTAINING HORMONES, PACKAGED FOR RETAIL SALE: VIKTOZA«, SOLUTION FOR INJECTION, 6 MG/ML, 3 ML EACH IN CARTRIDGES INSERTED IN A PRE-FILLED MULTI-DOSE DISPOSABLE SYRINGE PEN; 2 PRE-FILLED SYRINGE PENS IN A CARDBOARD BOX SERIES NS6JV52 - 5829 UNITS. (ACTIVE SUBSTANCES: 1 ML OF SOLUTION CONTAINS 6 MG OF LIRAGLUTIDE - AN ANALOGUE OF HUMAN GLUCAGON-LIKE PEPTIDE-1 (GLP-1), PRODUCED USING RECOMBINANT DNA TECHNOLOGY IN SACCHAROMYCES CEREVISIAE. ONE PRE-FILLED PEN CONTAINS 18 MG OF LIRAGLUTIDE IN 3 ML) TRADE MARK: VICTOZA COUNTRY OF MANUFACTURE: DK MANUFACTURER: A/T NOVO NORDISK (MANUFACTURER, BULK PRODUCT, FILLING, PRIMARY PACKAGING, QUALITY CONTROL AND RESPONSIBLE FOR THE RELEASE OF BATCHES OF THE FINAL PRODUCT; MANUFACTURER FOR ASSEMBLY, LABELING AND PACKAGING, SECONDARY PACKAGING) | |
|
DENMARK | UKRAINE | 0 |
| 9018321000 | 1. MEDICAL PRODUCTS: SINGLE-USE NEEDLES, STERILE, TUBULAR, METAL, PACKAGED FOR RETAIL SALE FOR USE WITH NOVOFINE« 30G X 8MM SYRINGE PENS, NO. 100 SERIES MS7F18X-1 - 480 UNITS. TRADE MARK: NOVOFINECOUNTRY OF MANUFACTURE: JPPRODUCTION OF THE COMPANY: NOVO NORDISK A /S | |
|
JAPAN | UKRAINE | 0 |
| 3004310000 | 1. MEDICINES FOR HUMANS CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: MIXSTARD« 30 NM FLEXPEN«, SUSPENSION FOR INJECTION, 100 IU/ML IN 3 ML CARTRIDGES; 1 CARTRIDGE IN A MULTI-DOSE DISPOSABLE PEN; 5 SYRINGE PENS IN A CARDBOARD BOX SERIES NR7MH78 - 2160 UNITS (1 ML OF SUSPENSION FOR INJECTION CONTAINS 100 IU OF HUMAN BIOSYNTHETIC INSULIN (RECOMBINANT DNA OBTAINED FROM SACCHAROMYCES CEREVISIAE); 1 IU (INTERNATIONAL UNIT) IS EQUAL TO 0.035 MG OF ANHYDROUS HUMAN INSULIN; 1 MULTI-DOSE DISPOSABLE PEN CONTAINS 3 ML OF SUSPENSION FOR INJECTION, EQUIVALENT TO 300 IU; MIXTARD« 30 NM FLEXPEN« IS A MIXTURE OF SOLUBLE INSULIN AND ISOPHANE INSULIN (NPH), WHICH CONTAINS 30% SOLUBLE INSULIN AND 70% ISOPHANE INSULIN) TRADEMARK: MIXSTARD, FLEXPEN COUNTRY OF MANUFACTURE: BR MANUFACTURER: NOVO NORDISK PRODUCAO PHARMACEUTICA DO BRASIL LTDA. (PRODUCER OF BULK PRODUCT, PRIMARY PACKAGING; PRODUCT QUALITY CONTROL IN PRIMARY PACKAGING (PENFIL« CARTRIDGES); COLLECTION, LABELING AND RECYCLING | |
|
BRAZIL | UKRAINE | 0 |
| 3004310000 | 1. MEDICINES FOR HUMANS CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: PROTAFAN« NM FLEXPEN«, SUSPENSION FOR INJECTION, 100 IU/ML; 3 ML EACH IN A CARTRIDGE; 1 CARTRIDGE IN A MULTI-DOSE DISPOSABLE PEN; 5 SYRINGE PENS IN A CARDBOARD BOX SERIES NR7MJ19 - 4320 UNITS (1 ML OF SUSPENSION FOR INJECTION CONTAINS 100 IU OF HUMAN BIOSYNTHETIC INSULIN (RECOMBINANT DNA OBTAINED FROM SACCHAROMYCES CEREVISIAE); 1 IU (INTERNATIONAL UNIT) IS EQUAL TO 0.035 MG OF ANHYDROUS HUMAN INSULIN; 1 MULTIDOSE DISPOSABLE PEN CONTAINS 3 ML OF SUSPENSION FOR INJECTION, EQUIVALENT TO 300 IU; PROTAFAN« NM FLEXPEN« IS AN ISOPHANE (NPH) INSULIN SUSPENSION)TRADEMARK: PROTAFAN, FLEXPENCOUNTRY OF MANUFACTURE: BR MANUFACTURER: NOVO NORDISK PRODUCAO PHARMACEUTICA DO BRASIL LTDA . (MANUFACTURER OF UNPACKAGED PRODUCT, PRIMARY PACKAGING; PRODUCT QUALITY CONTROL IN PRIMARY PACKAGING (PENFIL« CARTRIDGES); ASSEMBLY, LABELING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT (FLEXPEN«); QUALITY CONTROL OF THE FINISHED PRODUCT (FLEXP | |
|
BRAZIL | UKRAINE | 0 |
| 3004310000 | 1. MEDICINES FOR HUMANS CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: LEVEMIR« FLEXPEN«, SOLUTION FOR INJECTION, 100 UNITS/ML OF 3 ML IN A CARTRIDGE, 1 CARTRIDGE IN A MULTI-DOSE DISPOSABLE SYRINGE PEN; 5 SYRINGE PENS IN A CARDBOARD BOX SERIES MR7GV50 - 2430 UNITS. (ACTIVE SUBSTANCES: 1 ML OF SOLUTION FOR INJECTION CONTAINS 100 UNITS (14.2 MG) OF INSULIN DETEMIR (RDNA); 1 PRE-FILLED SYRINGE PEN CONTAINS 3 ML, WHICH IS EQUIVALENT TO 300 UNITS; 1 UNIT (U) OF INSULIN DETEMIR CORRESPONDS TO 1 MO OF HUMAN INSULIN) TRADE MARK: LEVEMIR, FLEXPEN COUNTRY OF MANUFACTURE: BR MANUFACTURER: NOVO NORDISK PRODUCAO PHARMACEUTICA DO BRASIL LTDA. (MANUFACTURER OF BULK PRODUCTS, FILLING IN PENFIL«, PRIMARY PACKAGING AND ASSEMBLY, MARKING AND PACKAGING OF FLEXPEN«, SECONDARY PACKAGING) | |
|
BRAZIL | UKRAINE | 0 |
| 9018321000 | 1. MEDICAL PRODUCTS: NEEDLES DISPOSABLE, TUBULAR, METAL, PACKAGED FOR RETAIL TRADE FOR USE WITH SYRINGES-PENS NOVOFINE® 30G X 8MM, #100 SERIES MS7K09S-B - 960UP. TRADEMARK: NOVOFAY COUNTRY OF PRODUCTION: JP MANUFACTURER: NOVO NORDISK A/ S | |
|
JAPAN | UKRAINE | 0 |
| 3004310000 | 1. HUMAN MEDICINES CONTAINING INSULIN AS PACKAGED FOR RETAIL SALE: XALTOFAY® SOLUTION FOR INJECTION, 100 UNITS/ML AND 3.6 MG/ML IN A 3ML CARTRIDGE CONTAINED IN A PREFILLED MULTIDOSE AND A DISPOSABLE SYRINGE -PENS, 5 PRE-FILLED SYRINGES IN A CARDBOARD BOX SERIES NZF7K91 - 7964UP. (1 ML OF SOLUTION CONTAINS 100 UNITS OF INSULIN DEGLUDEC* AND 3.6 MG OF LIRAGLUTIDE. 1 PRE-FILLED SYRINGE CONTAINS 3 ML EQUIVALENT TO 300 UNITS OF INSULIN DEGLUDEC AND 10.8 MG LIRAGLUTIDE *PRODUCED BY RECOMBINANT DNA TECHNOLOGY IN SACCHAROMYCES CEREVISIAE) TRADEMARK: XALTOFAIKRAIN MANUFACTURER: US MANUFACTURER: NOVO NORDISK PHARMACEUTICAL INDUSTRIES, LP (PRODUCT MANUFACTURER, CARTRIDGE FILLING AND PRODUCT QUALITY CONTROL; PACKAGING, LABELING AND SECONDARY PACKAGING OF THE FINISHED MEDICINAL PRODUCT TOOL) | |
|
UNITED STATES | UKRAINE | 0 |
| 3004310000 | 1. HUMAN MEDICINES CONTAINING INSULIN, PACKAGED FOR RETAIL SALE: TRESIBA® FLEXTACH®, SOLUTION FOR INJECTION, 100 UNITS/ML, IN A CARTRIDGE CONTAINED IN A MULTI-DOSE DISPOSABLE SYRINGE, PO 5 SYRINGE- PEN IN A CARTON BOX SERIES NP5K111 - 6480UP. (ACTIVE INGREDIENTS: 1 ML OF SOLUTION CONTAINS 100 UNITS OF INSULIN DEGLUDEC (EQUIVALENT TO 3.66 MG OF INSULIN DEGLUDEC), 1 PRE-FILLED SYRINGE CONTAINS 3 ML OZLIN EQUIVALENT TO 300 UNITS OF INSULIN DEGLUDEC) COMMERCIAL BRAND: TRESIBA, FLEXTATCH COUNTRY OF PRODUCTION: DK MANUFACTURER: A/T NOVO NORDISK (MANUFACTURING, FILLING IN PRIMARY PACKAGING AND BEAM CONTROL; PACKAGING, MARKING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT; QUALITY CONTROL OF THE FINISHED PRODUCT BEAM RESPONSIBLE FOR RELEASE OF TU AND FINISHED PRODUCT | |
|
DENMARK | UKRAINE | 0 |
| 3004390000 | 1. DRUGS FOR HUMANS CONTAINING HORMONES AS PACKAGED FOR RETAIL: SAXENDA® SOLUTION FOR INJECTION, 6MG/ML; 3ML EACH IN CARTRIDGES INSTALLED IN A PRE-FILLED MULTI-DOSE DISPOSABLE SYRINGE PEN; 3 PRE-FILLED SYRINGES IN A CARDBOARD BOX SERIES NP5K155 - 2556 UNITS, SERIES PP5L181 - 6056 UNITS, SERIES PP5L347 - 64 UNITS (1ML OF SOLUTION CONTAINS 6MG LIRAGLUTIDE - AN ANALOGUE OF HUMAN GLUCAGON SIMILAR PEPTIDE-1 (GPP-1), MANUFACTURED BY RECOMBINANT TECHNOLOGY DNA IN SACCHAROMYCES CEREVISIAE; ONE PRE-FILLED SYRINGE CONTAINS 18MG LIRAGLUTIDE IN 3ML) TRADEMARK: SAXENDAKRAIN MANUFACTURER: DKMANUFACTURER: A/T NOVO NORDISK (FINISHING, LABELING AND REPACKAGING PRODUCT PRODUCTION, CARTRIDGE FILLING AND CONTROL PRODUCT QUALITIES IN BULK. SERIES RELEASE AND CERTIFICATION) | |
|
DENMARK | UKRAINE | 0 |
| 3004310000 | 1. HUMAN MEDICINES CONTAINING INSULIN, PACKAGED FOR RETAIL: ACTRAPID® NM FLEXPEN®, SOLUTION FOR INJECTION, 100 IU/ML; 3 ML IN A CARTRIDGE; 1 CARTRIDGE IN MULTI-DOSE DISPOSABLE SYRINGE-PEN; 5 SYRINGE-PEN IN A CARDBOARD BOX SERIES NR7PL92 - 3900 UNITS, SERIES NR7PL93 - 17863 UNITS (1 ML OF SOLUTION FOR INJECTION CONTAINS 100 IU HUMAN BIOSYNTHETIC INSULIN (RECOMBINANT DNA DERIVED FROM SACCHAROMYCES CEREVISIAE ); 1 MU (INTERNATIONAL UNIT) IS EQUAL TO 0.035 MG INSULIN ANHYDROUS HUMAN; 1 MULTI-DOSE DISPOSABLE SYRINGE CONTAINS 3 ML OF SOLUTION FOR INJECTION EQUIVALENT TO 300 IU) TRADEMARK: ACTRAPID, FLEXPEN COUNTRY OF MANUFACTURE: BRMANUFACTURER: NOVO NORDISK PRODUCAO F ARMACEUTICA TO BRAZIL LTDA. (MANUFACTURER OF NON -COATED PRODUCT, PRIMARY PACKAGING; PRODUCT QUALITY CONTROL IN PRIMARY PACKAGING (PENFIL® CARTRIDGE); HARVESTING, MARKING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT (FLEXPEN®); QUALITY CONTROL OF FINISHED PRODUCT (FLEXPEN®) | |
|
BRAZIL | UKRAINE | 0 |
| 3004310000 | 1. HUMAN MEDICINES FOR THERAPEUTIC USE CONTAINING INSULIN, PACKAGED FOR RETAIL: NOVOMIX®30 FLEXPEN®, SUSPENSION FOR INJECTION, 100 UNITS/ML; 3 ML EACH IN A CARTRIDGE INSTALLED IN A MULTI-DOSE DISPOSABLE SYRINGE-PEN; 5 SYRINGES-PENS IN A CARDBOARD BOX SERIES NT6CK68 - 6522UP. (1 ML SUSPENSION FOR INJECTION CONTAINS 100 UNITS/ML INSULIN ASPARTH (RDNK) (30% SOLUBLE INSULIN ASPARTH AND 70% INSULIN ASPARTH CRYSTALLISED WITH PROTAME NOM); 1 SYRINGE -PEN CONTAINS 3 ML EQUIVALENT TO 300 UNITS; 1 UNIT (UNIT) EQUIVALENT TO 6 NMOL OR 0.035 MG OF DESALATED ANHYDROUS INSULIN ASPARTH) TRADEMARK: NOVOMYKS, FLEXPEN COUNTRY OF MANUFACTURE: FR MANUFACTURER: NOVO NORDISK PRODUCTS JON SAS (FULL CYCLE PRODUCT MANUFACTURER) | |
|
FRANCE | UKRAINE | 0 |
| 3004310000 | 1. HUMAN MEDICINES CONTAINING INSULIN, PACKAGED FOR RETAIL: PROTAFAN® NM, SUSPENSION FOR INJECTION, 100 IU/ML; 10 ML IN A VIAL; 1 VIAL IN A CARDBOARD BOX SERIES NT6BP52 - 16800UP. (1 ML OF SUSPENSION FOR INJECTION CONTAINS 100 IU (3.5 MG) OF HUMAN BIOSYNTHETIC INSULIN (ISOPHANE-INSULIN CRYSTALS), PRODUCED BY RDNK TECHNOLOGY IN SACCHAR OMYCES CEREVISIAE; 1 VIAL CONTAINS 10 ML EQUIVALENT TO 1000 IU; 1 IU (INTERNATIONAL UNIT) EQUIVALENT TO 0.035 MG OF ANHYDROUS HUMAN INSULIN) TRADEMARK: PROTAFANKRAIN MANUFACTURER: FRMANUFACTURER: NOVO NORDISK PRODUCTION S.A.S. CYCLE) | |
|
FRANCE | UKRAINE | 0 |
| 3004310000 | 1. HUMAN MEDICINES CONTAINING INSULIN AS PACKAGED FOR RETAIL: TRESIBA® FLEXTAC® SOLUTION FOR INJECTION, 100 UNITS/ML, 3ML IN A CARTRIDGE CONTAINED IN A MULTI-DOSE DISPOSABLE SYRINGE, 5 SYRINGE- PEN IN CARTON BOX SERIES NP5K007 - 6144UP. (ACTIVE INGREDIENTS: 1 ML OF SOLUTION CONTAINS 100 UNITS OF INSULIN DEGLUDEC (EQUIVALENT TO 3.66 MG OF INSULIN DEGLUDEC), 1 PRE-FILLED SYRINGE-PEN CONTAINS 3 ML ACTION EQUIVALENT TO 300 UNITS OF INSULIN DEGLUDEC) COMMERCIAL BRAND: TRESIBA, FLEXTATCH COUNTRY OF PRODUCTION: DKMANUFACTURER: A/T NOVO NORDISK (MANUFACTURING, FILLING IN PRIMARY PACKAGING AND BEAM CONTROL; PACKAGING, MARKING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT; QUALITY CONTROL OF THE FINISHED PRODUCT BEAM AND FINAL FINISHED PRODUCT; RESPONSIBLE FOR RELEASE) | |
|
DENMARK | UKRAINE | 0 |
| 3004310000 | 1. HUMAN MEDICINES CONTAINING INSULIN, PACKAGED FOR RETAIL TRADE: RAYSODEG® FLEXTACH®, SOLUTION FOR INJECTION, 100 UNITS/ML; 3ML IN A CARTRIDGE CONTAINED IN A MULTI-DOSE DISPOSABLE SYRINGE PEN, 5 SYRINGES IN A CARTON SERIES NP5J636 - 7287UP.(1ML SOLUTION CONTAINS 100 UNITS OF INSULIN DEGLUDEC/INSULIN ASPARTE* WHICH CONTAINS 70% INSULIN DEGLUDEC (EQUIVALENT TO 2 .56 MG) AND 30% INSULIN ASPARTE (EQUIVALENT TO 1.05 MG). 1 PRE-FILLED SYRINGE CONTAINS 3 ML OF SOLUTION EQUIVALENT TO 300 U INSULIN DEGLUDEC/INSULIN ASPARTE) TRADE BRAND: RAYSODEG, FLEXTACRA ITS MANUFACTURER: DK MANUFACTURER: A/ T NOVO NORDISK (MANUFACTURING, FILLING IN PRIMARY PACKAGING AND BEAM CONTROL, RESPONSIBLE FOR RELEASE; PACKING, LABELING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT; QUALITY CONTROL OF THE FINISHED PRODUCT BEAM AND THE FINAL FINISHED PRODUCT) | |
|
DENMARK | UKRAINE | 0 |
| 3004390000 | 1. DRUGS FOR HUMANS CONTAINING HORMONES AS PACKAGED FOR RETAIL: SAXENDA® SOLUTION FOR INJECTION, 6MG/ML; 3ML EACH IN CARTRIDGES INSTALLED IN A PRE-FILLED MULTI-DOSE DISPOSABLE SYRINGE PEN; 3 PRE-FILLED SYRINGES-PENS IN A CARDBOARD BOX SERIES NP5K138 - 11776 UNITS (1ML OF SOLUTION CONTAINS 6MG LIRAGLUTIDE - AN ANALOGUE OF HUMAN GLUCAGON-LIKE PEPTIDE-1 (GLP-1), MANUFACTURED USING RECOMBINANT TECHNOLOGY NOI DNA IN SACCHAROMYCES CEREVISIAE; ONE PRE-FILLED SYRINGE CONTAINS 18MG LIRAGLUTIDE IN 3ML) TRADEMARK: SAXENDAKRAIN MANUFACTURER: DKMANUFACTURER: A/T NOVO NORDISK (ASSEMBLING, LABELING AND SECONDARY PACKAGING OF THE FINISHED PRODUCT. BATCH CERTIFICATION; PRODUCT MANUFACTURING, CARTRIDGE FILLING INSPECTION AND QUALITY CONTROL OF IN BULK PRODUCTS. BATCH RELEASE AND CERTIFICATION) | |
|
DENMARK | UKRAINE | 0 |
| 9018321000 | 1. MEDICAL PRODUCTS: DISPOSABLE STERILE, TUBULAR, METAL NEEDLES, PACKAGED FOR RETAIL TRADE FOR USE WITH SYRINGES-PENS NOVOFINE® 30G X 8MM, #100 SERIES MS7K09S-B - 480UP. TRADEMARK: NOVOFAY COUNTRY OF PRODUCTION: JP MANUFACTURER: NOVO NORDISK A/ S" | |
|
JAPAN | UKRAINE | 0 |
| 3004310000 | 1. HUMAN MEDICINES CONTAINING INSULIN, PACKAGED FOR RETAIL: LEVEMIR® FLEXPEN®, SOLUTION FOR INJECTION, 100 UNITS/ML OF 3ML IN A CARTRIDGE, 1 CARTRIDGE IN A MULTI-DOSE DISPOSABLE SYRINGE-PEN; 5 SYRINGES-PENS IN A CARDBOARD BOX SERIES NR7SS73 - 3326UP. (ACTIVE INGREDIENTS: 1 ML OF SOLUTION FOR INJECTION CONTAINS 100 UNITS (14.2 MG) OF INSULIN DETEMIR (RDNK); 1 PRE-FILLED SYRINGE CONTAINS 3 ML, EQUIVALENT TO 300 UNITS; 1 UNIT (UNIT) OF INSULIN DETEMIR R CORRESPONDS 1 MO HUMAN INSULIN) TRADEMARK: LEVEMIR, FLEXPENKRAIN MANUFACTURER: BRMANUFACTURER: NOVO NORDISK PRODUCAO PHARMACEUTICA TO BRAZIL LTDA. (MANUFACTURER OF UNPACKAGED PRODUCTS, PENFILL® FILLING, PRIMARY PACKAGING AND ASSEMBLY, FLEXPEN® MARKING AND PACKAGING, SECONDARY PACKAGING)" | |
|
BRAZIL | UKRAINE | 0 |
| 3004310000 | 1. HUMAN MEDICINES CONTAINING INSULIN AS PACKAGED FOR RETAIL: MIXSTARD® 30 NM SUSPENSION FOR INJECTION, 100 IU/ML IN 10ML VIAL; 1 VIAL IN A CARTON SERIES NT6BM03 - 10834UP. (1 ML OF INJECTION SUSPENSION CONTAINS 100 IU (3.5 MG) HUMAN BIOSYNTHETIC INSULIN, 30% SOLUBLE INSULIN, 70% ISOPHANE INSULIN , PRODUCED BY RDNK TECHNOLOGY IN SACCHAROMYCES CEREVISIAE; 1 VIAL CONTAINS 10 ML, EQUIVALENT TO 1000 IU; 1 IU IS 0.035 MG OF ANHYDROUS HUMAN INSULIN. JON SAS (FULL CYCLE PRODUCT MANUFACTURER)" | |
|
FRANCE | UKRAINE | 0 |
| 3004310000 | 1. HUMAN MEDICINES CONTAINING INSULIN, PACKAGED FOR RETAIL: PROTAFAN® NM, SUSPENSION FOR INJECTION, 100 IU/ML; 10 ML IN A VIAL; 1 VIAL IN A CARTON SERIES NT6BP53 - 7680UP. (1 ML OF SUSPENSION FOR INJECTION CONTAINS 100 IU (3.5 MG) OF HUMAN BIOSYNTHETIC INSULIN (ISOPHANE CRYSTALS), PRODUCED BY RDNK TECHNOLOGY IN SACCHAR OMYCES CEREVISIAE; 1 VIAL CONTAINS 10 ML, EQUIVALENT TO 1000 IU; 1 IU (INTERNATIONAL UNIT) EQUIVALENT TO 0.035 MG OF ANHYDROUS HUMAN INSULIN) TRADEMARK: PROTAFANKRAIN MANUFACTURER: FR MANUFACTURER: NOVO NORDISK PRODUCTION S.A.S. IN CYCLE)" | |
|
FRANCE | UKRAINE | 0 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Why should you choose Eximpedia?
Broad Range of Country Datasets
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
Easy to understand deep analysis
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
Most Accurate Information
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Competitive Supplier Engagement Watch
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
Right away on-screen support
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Access Database Across 130+ Countries
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
Tov Novo Nordisk Ukraine frequently asked questions
You can explore detailed shipment records of Tov Novo Nordisk Ukraine through Eximpedia’s real-time trade insights platform, which provides access to shipment dates, quantities, ports, and product details.
Yes, Eximpedia offers a directory of buyers with similar trade patterns to Tov Novo Nordisk Ukraine. Use advanced filters to identify competitors or partners in the same industry.
With our data-driven platform, you can access a curated list of suppliers with comparable product categories and shipment volumes to Tov Novo Nordisk Ukraine, helping you expand your sourcing network.
Eximpedia’s trade data highlights Tov Novo Nordisk Ukraine’s major exports, along with their trade destinations and origins.
We provide detailed analytics, including trade volumes, market trends, port usage, and competitor insights, to help businesses understand Tov Novo Nordisk Ukraine’s trade activities.
Traders can collaborate with Tov Novo Nordisk Ukraine by contacting them through their official channels or visiting their headquarters for detailed trade discussions.